If you are shopping for a peptide through a legitimate provider, the first question is not which compound sounds most promising. It is whether the compound can be dispensed legally at all. The regulatory status of a peptide shapes where you can get it, what it costs, and whether the seller in front of you is operating inside the law.
That status varies a lot from one peptide to the next. Here is how the picture looks for five that come up constantly in these comparisons.
Semaglutide sits in a different category than the rest
Of the peptides people ask about, semaglutide is the outlier because it is FDA approved. It is the active ingredient in branded products cleared for specific uses, and it reaches patients through ordinary prescriptions filled at licensed pharmacies. That is the cleanest path available for any peptide on this list.
Compounded versions became widely available while the branded products were in shortage. When the FDA considers a shortage resolved, the legal basis for large-scale compounding of that drug narrows. If a provider is offering compounded semaglutide, it is worth asking how they justify it under current shortage status and which type of pharmacy is preparing it.
BPC-157, TB-500, CJC-1295, and ipamorelin are investigational
BPC-157, TB-500, CJC-1295, and ipamorelin are not FDA approved for any use. They are investigational compounds. The FDA has also scrutinized whether several of them belong on the lists that let compounding pharmacies use them as bulk drug substances, and that scrutiny has restricted how a compliant pharmacy can source and prepare them.
This matters directly. When a compound cannot be lawfully compounded, the products you see advertised are often coming from research-chemical vendors rather than licensed pharmacies. Those vendors sell material labeled for laboratory use only, not for human use, and they operate outside the prescription system entirely.
What drives the cost
For an approved drug like semaglutide, cost reflects the branded product's pricing, insurance coverage, and whether a compounded version is legally in play. For the investigational peptides, price is driven by the pharmacy's sourcing, the cost of the raw material, purity testing, and the clinical oversight bundled into a telehealth visit. A suspiciously low price usually signals that one of those steps was skipped, most often the licensed pharmacy itself.
How to vet a provider
The regulatory background gives you concrete questions to ask before you commit.
- Does a licensed clinician evaluate you and write an actual prescription, or does the site just take an order?
- Which pharmacy fills it, and is it a 503A or 503B facility you can verify?
- For semaglutide, how do they justify compounding under the current shortage status?
- For the investigational peptides, are they candid that these are not FDA approved?
- Do they publish certificates of analysis or third-party testing for what they dispense?
A provider that answers these plainly is easier to trust than one that leans on marketing language. Vague claims and no named pharmacy are red flags regardless of how the website looks.
The practical takeaway
Approval status is not a detail. It determines whether the peptide can reach you legally and through whom. Semaglutide travels the standard prescription route. The others remain investigational, and their legitimate availability is narrow and contested. Use that as your baseline when comparing providers, and take any specific decision to a licensed clinician who can look at your situation. This article is general information, not medical advice.